business
Imunon Secures $10 Million Funding Package to Advance Phase 3 Ovarian Cancer Study (IMNN)
Imunon Secures $10 Million Funding Package to Advance Phase 3 Ovarian Cancer Study (IMNN)
Read full story on Yahoo Finance → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop